Accès gratuit
Med Sci (Paris)
Volume 21, Numéro 3, Mars 2005
Page(s) 273 - 278
Section M/S revues
Publié en ligne 15 mars 2005
  1. Smith CL, O’Malley BW. Coregulator function : a key to understanding tissue specificity of selective receptor modulators. Endocrinol Rev 2004; 25 : 45–71.
  2. Cavailles V, Dauvois S, L’Horset F, et al. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J 1995; 14 : 3741–51.
  3. Lee CH, Chinpaisal C, Wei LN. Cloning and characterization of mouse RIP140, a corepressor for nuclear orphan receptor TR2. Mol Cell Biol 1998; 18 : 6745–55.
  4. L’Horset F, Dauvois S, Heery DM, et al. RIP-140 interacts with multiple nuclear receptors by means of two distinct sites. Mol Cell Biol 1996; 16 : 6029–36.
  5. Heery DM, Hoare S, Hussain S, et al. Core LXXLL motif sequences in CREB-binding protein, SRC1, and RIP140 define affinity and selectivity for steroid and retinoid receptors. J Biol Chem 2001; 276 : 6695–702.
  6. Subramaniam N, Treuter E, Okret S. Receptor interacting protein RIP140 inhibits both positive and negative gene regulation by glucocorticoids. J Biol Chem 1999; 274 : 18121–7.
  7. Kumar MB, Tarpey RW, Perdew GH. Differential recruitment of coactivator RIP140 by Ah and estrogen receptors. Absence of a role for LXXLL motifs. J Biol Chem 1999; 274 : 22155–64.
  8. Teyssier C, Belguise K, Galtier F, et al. Receptorinteracting protein 140 binds c-Jun and inhibits estradiol-induced activator protein-1 activity by reversing glucocorticoid receptor-interacting protein 1 effect. Mol Endocrinol 2003; 17 : 287–99.
  9. Panda S, Antoch MP, Miller BH, et al. Coordinated transcription of key pathways in the mouse by the circadian clock. Cell 2002; 109 : 307–20.
  10. Cavailles V, Dauvois S, Danielian PS, Parker MG. Interaction of proteins with transcriptionally active estrogen receptors. Proc Natl Acad Sci USA 1994; 91 : 10009–13.
  11. Thenot S, Charpin M, Bonnet S, Cavailles V. Estrogen receptor cofactors expression in breast and endometrial human cancer cells. Mol Cell Endocrinol 1999; 156 : 85–93.
  12. Kerley JS, Olsen SL, Freemantle SJ, Spinella MJ. Transcriptional activation of the nuclear receptor corepressor RIP140 by retinoic acid : a potential negative-feedback regulatory mechanism. Biochem Biophys Res Commun 2001; 285 : 969–75.
  13. White R, Leonardsson G, Rosewell I, et al. The nuclear receptor co-repressor nrip1 (RIP140) is essential for female fertility. Nat Med 2000; 6 : 1368–74.
  14. Katsanis N, Ives JH, Groet J, et al. Localisation of receptor interacting protein 140 (RIP140) within 100 kb of D21S13 on 21q11, a gene-poor region of the human genome. Hum Genet 1998; 102 : 221–3.
  15. FitzPatrick DR, Ramsay J, McGill NI, et al. Transcriptome analysis of human autosomal trisomy. Hum Mol Genet 2002; 11 : 3249–56.
  16. Zilliacus J, Holter E, Wakui H,et al. Regulation of glucocorticoid receptor activity by 14—3-3-dependent intracellular relocalization of the corepressor RIP140. Mol Endocrinol 2001; 15 : 501–11.
  17. Tazawa H, Osman W, Shoji Y, et al. Regulation of subnuclear localization is associated with a mechanism for nuclear receptor corepression by RIP140. Mol Cell Biol 2003; 23 : 4187–98.
  18. An J, Ribeiro RC, Webb P, et al. Estradiol repression of tumor necrosis factor-α transcription requires estrogen receptor activation function-2 and is enhanced by coactivators. Proc Natl Acad Sci USA 1999; 96 : 15161–6.
  19. Joyeux A, Cavailles V, Balaguer P, Nicolas JC. RIP 140 enhances nuclear receptor-dependent transcription in vivo in yeast. Mol Endocrinol 1997; 11 : 193–202.
  20. Henttu PM, Kalkhoven E, Parker MG. AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors. Mol Cell Biol 1997; 17 : 1832–9.
  21. Treuter E, Albrektsen T, Johansson L, et al. A regulatory role for RIP140 in nuclear receptor activation. Mol Endocrinol 1998; 12 : 864–81.
  22. Wei LN, Hu X, Chandra D, et al. Receptor-interacting protein 140 directly recruits histone deacetylases for gene silencing. J Biol Chem 2000; 275 : 40782–7.
  23. Castet A, Boulahtouf A, Versini G, et al. Multiple domains of the receptor-interacting protein 140 contribute to transcription inhibition. Nucleic Acids Res 2004; 32 : 1957–66.
  24. Christian M, Tullet JM, Parker MG. Characterisation of four autonomous repression domains in the corepressor RIP140. J Biol Chem 2004; 279 : 15645–51.
  25. Vo N, Fjeld C, Goodman RH. Acetylation of nuclear hormone receptor-interacting protein RIP140 regulates binding of the transcriptional corepressor CtBP. Mol Cell Biol 2001; 21 : 6181–8.
  26. Leonardsson G, Jacobs MA, White R, et al. Embryo transfer experiments and ovarian transplantation identify the ovary as the only site in which nuclear receptor interacting protein 1/RIP140 action is crucial for female fertility. Endocrinology 2002; 143 : 700–7.
  27. Lim H, Paria BC, Das SK, et al. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell 1997; 91 : 197–208.
  28. Leonardsson G, Steel JH, Christian M, et al. Nuclear receptor corepressor RIP140 regulates fat accumulation. Proc Natl Acad Sci USA 2004; 101 : 8437–42.
  29. Wang YX, Lee CH, Tiep S, Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell 2003; 113 : 159–70.
  30. Rouayrenc JF, Castet A, Rey JM, et al. Genetic alterations of transcription cofactors in solid tumors. Bull Cancer 2002; 89 : 357–64.
  31. White KA, Yore MM, Warburton SL, et al. Negative feedback at the level of nuclear receptor coregulation. Self-limitation of retinoid signaling by RIP140. J Biol Chem 2003; 278 : 43889–92.
  32. Radaelli T, Varastehpour A, Catalano P, Hauguel-de Mouzon S. Gestational diabetes induces placental genes for chronic stress and inflammatory pathways. Diabetes 2003; 52 : 2951–8.
  33. Baldus CD, Liyanarachchi S, Mrozek K, et al. Acute myeloid leukemia with complex karyotypes and abnormal chromosome 21 : amplification discloses overexpression of APP, ETS2 and ERG genes. Proc Natl Acad Sci USA 2004; 101 : 3915–20.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.